Development of an Electrochemical Immunosensor for Specific Detection of Visceral Leishmaniasis Using Gold-Modified

Beatriz R Martins1, Yanne O Barbosa1, Cristhianne M R Andrade2

  • 1Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro, Uberaba-MG 38025-180, Brazil.

Biosensors
|July 29, 2020
PubMed

Insights

This study introduces a novel electrochemical immunosensor for sensitive visceral leishmaniasis diagnosis. The biosensor achieves 100% specificity, overcoming limitations of traditional ELISA by preventing cross-reactions with Chagas disease.

Area of Science:

  • Immunosensors
  • Tropical Diseases
  • Electrochemical Biosensing

Background:

  • Visceral leishmaniasis diagnosis is challenged by low antibody levels in asymptomatic individuals and cross-reactivity with other diseases.
  • Existing diagnostic methods like ELISA exhibit low specificity due to cross-reactions, leading to inaccurate results.

Purpose of the Study:

  • To develop a highly sensitive electrochemical immunosensor for accurate visceral leishmaniasis diagnosis.
  • To ensure the immunosensor avoids cross-reactions with Chagas disease (CD), improving diagnostic specificity.

Main Methods:

  • Standardization of crude Leishmania infantum antigens for sensor engagement.
  • Development of a screen-printed carbon electrode modified with gold nanoparticles.
  • Testing serum samples from patients with visceral leishmaniasis and various forms of Chagas disease.

Main Results:

  • The gold nanoparticle-modified electrode effectively adsorbed antigens, enabling specific leishmaniasis recognition without Chagas disease cross-reactivity.
  • The immunosensor demonstrated high selectivity and 100% specificity, with no false positives or negatives for visceral leishmaniasis and Chagas disease.
  • Comparative analysis showed ELISA had 44% specificity due to cross-reactions, while the immunosensor achieved superior performance.

Conclusions:

  • The developed electrochemical immunosensor offers a sensitive and highly specific diagnostic tool for visceral leishmaniasis.
  • This biosensor effectively differentiates visceral leishmaniasis from Chagas disease, addressing a critical diagnostic challenge.
  • The technology shows promise for improved neglected tropical disease diagnostics, with stability for 5 days and a detection limit of 200 ng mL⁻¹.